Zelira Therapeutics Ltd. (ZLDAF)
0.26
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.093M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 14.54% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.60% |
Profile
| Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. It operates through the following geographical segments: Australia and USA. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia. |
| URL | http://zeliratx.com |
| Investor Relations URL | N/A |
| HQ State/Province | Western Australia (WA) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. It operates through the following geographical segments: Australia and USA. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia. |
| URL | http://zeliratx.com |
| Investor Relations URL | N/A |
| HQ State/Province | Western Australia (WA) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |